Cardiac transplantation: a review for the intensivists.
Cardiac transplantation has now become accepted therapy for the treatment of end-stage heart disease in both children and adults, and literally thousands of patients are bearers of cardiac grafts.  Because of these patients' susceptibility to infections, rejection, coronary disease, and malignancy, as well as to serious illnesses unrelated to their transplantation, they will often be encountered at hospital centers both close to their homes and distant from the site of their surgery.  The intensive care unit physician's role will be a demanding one when caring for these patients because of the broad differential diagnosis of infections, frequency of drug interactions and altered immunosuppression, and continuous uncertainty regarding the possibility of rejection, particularly during the first year after transplantation.
Division of Cardiovascular Medicine, Stanford University School of Medicine, CA 94305.
M G
MG
Perlroth
D003324:Coronary Artery Disease; D006084:Graft Rejection / Q000175:diagnosis / Q000628:therapy; D016027:Heart Transplantation / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007239:Infections; D008232:Lymphoproliferative Disorders; D011182:Postoperative Care; D009927:Tissue and Organ Procurement; D016896:Treatment Outcome